Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,089 studies match

clinicaltrialsPublishedShowing 51–100 of 1,089 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07630974	A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)	recruiting	Phase 1 / Phase 2	134	Merck Sharp & Dohme LLCINDUSTRY	10	Sep 25, 2026	clinicaltrials
NCT04306224	A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas	completed	Phase 1	12	ImmuneOncia Therapeutics Inc.INDUSTRY	2	Sep 24, 2026